Melatonin: Sleep Architecture, Circadian Rhythm, and Antioxidant Properties — The Oversimplified “Sleep Hormone” Decoded

Melatonin: Sleep Architecture, Circadian Rhythm, and Antioxidant Properties — The Oversimplified “Sleep Hormone” Decoded

Melatonin is the best-selling sleep supplement in the United States, with sales exceeding $1.5 billion annually. It is available in doses ranging from 0.3 mg to 20 mg, in formats from gummies to time-release tablets, and is marketed as the solution to every sleep problem imaginable. Tutela Medical finds this market deeply problematic — not because melatonin lacks evidence (it has more than most supplements), but because the dose escalation, indiscriminate use, and fundamental misunderstanding of what melatonin actually does have created a public health concern hiding in plain sight.

What Melatonin Is — And What It Is Not

Melatonin (N-acetyl-5-methoxytryptamine) is an endogenous hormone produced by the pineal gland in response to darkness. Its primary physiological function is circadian signaling — it tells the body when it is nighttime. It is a timekeeper, not a sedative. This distinction is critical and almost universally ignored in consumer messaging.

Melatonin production begins approximately 2 hours before habitual sleep onset (the “dim light melatonin onset” or DLMO), peaks during the biological night, and suppresses at dawn. Exogenous melatonin supplementation works best when it corrects a circadian timing problem — jet lag, delayed sleep phase, shift work — rather than when it is used as a generic knockout pill for garden-variety insomnia.

Evidence by Sleep Application

The Dose Problem: Less Is Almost Certainly More

This is Tutela Medical’s most important finding in the melatonin category. Physiological melatonin production generates blood levels equivalent to approximately 0.1–0.3 mg of oral supplementation. The most effective clinical trials for circadian resetting use 0.5–3 mg. Yet the average retail melatonin product contains 5–10 mg, and products containing 20 mg are readily available.

Higher doses do not produce proportionally better sleep. Research suggests that doses above 1–3 mg may actually desensitize melatonin receptors, cause morning grogginess, and disrupt normal circadian feedback loops. A landmark MIT study found that 0.3 mg was the optimal dose for improving sleep quality in older adults — approximately 1/30th of what many consumers take nightly.

Additionally, a 2023 analysis found that melatonin supplement labels are frequently inaccurate. The actual melatonin content varied by -83% to +478% from what was stated on the label. Some products also contained undisclosed serotonin. The supplement industry’s quality control failures in this category are alarming.

Drug Interactions

• Fluvoxamine (Luvox): Dramatically increases melatonin levels by inhibiting CYP1A2 metabolism. This combination can cause excessive sedation and should be medically supervised.
• Anticoagulants (warfarin): Melatonin may enhance anticoagulant effects. Monitor INR.
• Antihypertensives: Melatonin may lower blood pressure. Additive effect with blood pressure medications.
• Diabetes medications: Melatonin may affect glucose metabolism. Monitor blood sugar in diabetic patients.
• Immunosuppressants: Melatonin has immunomodulatory properties and may theoretically counteract immunosuppressive therapy.
• CNS depressants (benzodiazepines, alcohol): Additive sedation. Use with caution.
• Caffeine: Increases melatonin levels by inhibiting CYP1A2.

Who Should Consider Melatonin

• Frequent travelers crossing multiple time zones (the strongest evidence base)
• Individuals with delayed sleep-wake phase disorder (night owls who cannot fall asleep before 2–3 AM)
• Shift workers attempting to sleep during daylight hours
• Older adults with documented melatonin decline (production decreases with age)
• Parents of children with ASD or ADHD and chronic sleep onset delay (under pediatrician guidance)

Who Should Reconsider

• People taking 10–20 mg nightly for chronic insomnia — melatonin is not a sedative, and these doses are far above physiological levels
• Individuals whose insomnia is driven by anxiety, pain, or sleep apnea — melatonin does not address these causes
• Anyone who has not tried sleep hygiene interventions (consistent schedule, dark room, no screens before bed) before reaching for supplements
• Pregnant or breastfeeding women (insufficient safety data)
• Individuals with autoimmune conditions (immunomodulatory effects are unpredictable)

Tutela Medical’s Conclusion

Melatonin works — for the right people, at the right dose, for the right indication. Jet lag? Supported. Circadian rhythm disorders? Supported. General insomnia in someone who sleeps in a bright room with a phone in their face until midnight? Melatonin is a band-aid on a lifestyle problem.

Start with 0.5–1 mg, taken 30–60 minutes before desired bedtime. If that does not work, the problem is likely not melatonin deficiency. The supplement industry’s escalation of melatonin doses to 10–20 mg is not evidence-based — it is shelf-space competition masquerading as efficacy.

For related analysis, see our Supplement Reviews library and our Health Education section on sleep science.

*These statements have not been evaluated by the Food and Drug Administration. Supplements discussed are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before starting any supplement regimen.

TutelaMedical.com is an independent health research publication. Our content reflects independent analysis and does not constitute medical advice.